期刊
MEDICINAL CHEMISTRY RESEARCH
卷 28, 期 7, 页码 959-973出版社
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-019-02349-x
关键词
Ursolic acid; Aminoguanidine; Antibacterial activity; Anti-inflammatory activity; Cytotoxicity
资金
- National Natural Science Foundation of China [81260468, 81460524, 81060257]
- Natural Science Foundation of Jilin Province [20160101218JC]
- Edanz Group China
Three series of ursolic acid derivatives containing an aminoguanidine moiety were designed, synthesized, and evaluated for anti-bacterial and anti-inflammatory activity. Some compounds displayed potent anti-bacterial activity against Gram-positive bacterial strains (including multidrug-resistant clinical isolates) and Gram-negative bacterial strains, with minimum inhibitory concentration (MIC) values in the range of 2-64 mu g/mL. Compounds 3a, 5a, and 7l showed significant inhibitory activity against the Gram-positive bacterial strain Staphylococcus aureus RN 4220, the Gram-negative bacterial strain Escherichia coli 1924, and four multidrug-resistant Gram-positive bacterial strains, with MIC values of 2 and 4 mu g/mL. In anti-inflammatory tests, most of the compounds exhibited potent activity, in particular compound 3a displayed the most potent activity with 81.61% inhibition after intraperitoneal administration, which was more potent than ursolic acid and the reference drugs (ibuprofen and indomethacin). The cytotoxic activity of compound 3a was assessed in HeLa, Hep3B, and A549 cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据